BELASONE Leman ong tb 30 g
7680693730014
CH-69373
D07XC01
10.05.2.
1 / 3
google
Details
- Product number
- 6937301
- CPT
- -
- Packaging group
- 30
- Unit
- g
- Composition
- betamethasonum 0.5 mg ut betamethasoni dipropionas 0.64 mg, acidum salicylicum 30 mg, paraffinum liquidum, vaselinum album, ad unguentum pro 1 g.
Articles (1)
Belasone Leman, pommade
pommade
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.64 MG | Substance | WIZUS |
|
(N/A)
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 12.30
Specialties list
Yes
Generic
Yes
SL addition date:
01/12/2024
Authorization holder
Leman SKL SA
1213 Lancy
Authorization information
- Swissmedic authorization number
- 69373
- Drug name
- Belasone Leman, pommade
- Galenic form
- SALB
- ATC Code
- D07XC01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 05/04/2024
- Authorization expiration date
- 04/04/2029
- IT number
- 10.05.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BELASONE Leman ong tb 30 g
- Description (DE)
- BELASONE Leman Salbe Tb 30 g
- Market launch
- 05/04/2024
- Narcotic (BTM)
- No